New Microfluidic Device Revolutionizes Cell Therapy for Spinal Cord Injury Patients

MIT and Singapore-MIT Alliance for Research and Technology have developed a groundbreaking microfluidic device to enhance cell therapy for spinal cord injury patients. The device sorts and removes potentially harmful cells, improving safety and efficacy. It can process over 500 million cells per minute and is cost-effective for large-scale implementation, offering hope for improved treatment outcomes.